Do MCHC, MPV, and Procalcitonin Levels Determine Prognosis in Acute Coronary Syndrome?

Table 2

(a) Mann-Whitney U test for variance between ACS, gender, mortality, TVCAD, and complications in terms of values

PCT, MCHC, MPV, and GS
			n	%	Z	P
PCT	Gender	Female; Male	74; 126	37; 63	-1,077 -0,105; -0,346; -0,290	0,281
MCHC						0,916
MPV						0,729
GS						0,772
PCT	Mortality	No; Yes	182; 18	91; 9	-6,883 -2,182; -3,903; -3,303	0,001
MCHC						0,029
MPV						0,001
GS						0,001
PCT	TVCAD	No; Yes	135; 65	67,5; 32,5	-4,002 -0,707; -9,361; -6,860	0,001
MCHC						0,480
MPV						0,001
GS						0,001
Total			200	100

MCHC: Mean Corpuscular Hemoglobin Concentration, MPV: Mean Platelet Volume, ACS: Acute Coronary Syndrome, GS: Gensini Score, and PCT: Procalcitonin.

(b) Regarding values, the relationship between ACS, gender, mortality, TVCAD, and complications Kruskal Wallis H Test Result.

PCT, MCHC, MPV, and GS
			n	%	H	P
PCT	Complication	No; VT; APE; IHF	105; 16; 10; 69	52,5; 8; 5; 34,5	14,748 78,137; 13,238; 26,025	0,002
MCHC						0,001
MPV						0,004
GS						0,001
PCT	Mortality	İnferiorgroup; Anteriorgroup; NSTEMI; AU	50; 50; 50; 50	25; 25; 25; 25	11,496 135,189; 31,276; 68,404	0,001
MCHC						0,009
MPV						0,001
GS						0,001
Total			200	100